Agilis Biotherapeutics' Acquisition

Agilis Biotherapeutics was acquired by PTC Therapeutics on July 19, 2018.

Agilis Biotherapeutics focuses on advancing DNA therapeutics designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central nervous s…

Articles about Agilis Biotherapeutics' Acquisition: